Risperidone stands as a cornerstone in the management of severe mental health conditions, particularly schizophrenia, bipolar disorder, and irritability associated with autistic disorder. As an atypical antipsychotic, its efficacy in regulating neurotransmitter activity in the brain has made it an indispensable medication globally. For manufacturers, distributors, and healthcare providers, understanding the intricate web of Risperidone’s global buyers is crucial for effective market navigation, strategic sourcing, and ensuring patient access. This article provides an in-depth look at the global Risperidone market, outlining the major buyer segments, the critical factors influencing procurement, and prevailing market trends. Who Are the Global Buyers of Risperidone? The demand for Risperidone stems primarily from the healthcare…